Dobrochna Dolicka
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 7
- RNA Research and Splicing 4
- RNA regulation and disease 2
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- Co-authors
- Michelangelo Foti (11 shared papers)Cyril Sobolewski (10 shared papers)Marta Correia de Sousa (9 shared papers)Monika Gjorgjieva (8 shared papers)Margot Fournier (7 shared papers)Christine Maeder (7 shared papers)Flavien Berthou (3 shared papers)Nicolas Calo (2 shared papers)
- Journals
- International Journal of Molecular Sciences (4 papers)Cancers (2 papers)Gut (2 papers)Cellular and Molecular Gastroenterology and Hepatology (1 paper)Oncotarget (1 paper)
- Partner nations
- SwitzerlandUnited StatesPoland
In The Last Decade
Dobrochna Dolicka
13 papers receiving 1.0k citations
Dobrochna Dolicka's Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 493
- Molecular Biology 598
- Epidemiology 168
- Immunology 79
- Cell Biology 54
Countries citing papers authored by Dobrochna Dolicka
This map shows the geographic impact of Dobrochna Dolicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dobrochna Dolicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dobrochna Dolicka more than expected).
Fields of papers citing papers by Dobrochna Dolicka
This network shows the impact of papers produced by Dobrochna Dolicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dobrochna Dolicka. The network helps show where Dobrochna Dolicka may publish in the future.
Co-authors
The 25 scholars most cited alongside Dobrochna Dolicka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Deciphering miRNAs’ Action through miRNA Editing Hit paper breakdown → | 2019 | 643 |
| 2 | 2019 | 194 | |
| 3 | 2020 | 70 | |
| 4 | 2021 | 27 | |
| 5 | 2020 | 26 | |
| 6 | 2018 | 19 | |
| 7 | 2019 | 14 | |
| 8 | 2021 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2020 | 12 | |
| 11 | 2022 | 5 | |
| 12 | 2025 | 2 | |
| 13 | 2022 | 1 |
About Dobrochna Dolicka
Dobrochna Dolicka is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Nephrology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), MicroRNA in disease regulation (4 papers), RNA Research and Splicing (4 papers), Cancer-related molecular mechanisms research (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), RNA regulation and disease (2 papers), Adipose Tissue and Metabolism (1 paper) and Advanced Proteomics Techniques and Applications (1 paper). The work is most often cited by research in Cancer Research (493 citations), Molecular Biology (598 citations), Epidemiology (168 citations), Immunology (79 citations) and Cell Biology (54 citations). Dobrochna Dolicka has collaborated with scholars based in Switzerland, United States and Poland. Frequent co-authors include Michelangelo Foti, Cyril Sobolewski, Marta Correia de Sousa, Monika Gjorgjieva, Margot Fournier, Christine Maeder, Flavien Berthou, Nicolas Calo, Bostjan Humar and Jean‐François Dufour. Their work appears in journals such as International Journal of Molecular Sciences, Cancers, Gut, Cellular and Molecular Gastroenterology and Hepatology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.